COVID 19 Spike RBD (S477N) Coronavirus (COVID-19) Recombinant Protein

SARS-CoV-2 Spike RBD (S477N) Protein, C-terminal 6xHis-tagged, expressed and purified from 293 cells.

C-terminal 6xHis-tagged recombinant spike RBD (S477N) protein (aa 319-541) of SARS-CoV-2

The novel coronavirus (SARS-CoV-2), previously called 2019-nCoV, is a newly identified coronavirus causing the ongoing outbreak of atypical pneumonia in Wuhan China from late 2019.

The genome of SARS-CoV-2 has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain (RCB) of SARS-CoV-2 shares only 40% amino acid identity with other SARS-related coronaviruses.

Recombinant spike RBD (S477N) protein of SARS-CoV-2 expressed and purified from HEK293 cells.

Small volumes of COVID-19 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS434299 is a recombinant protein targeting COVID-19. Also known as Recombinant Spike RBD (S477N) Protein of SARS-CoV-2. Host: HEK293 Cells.